VTE Trial: As DOACs Face Off, Apixaban Confirmed Safer - Medscape

VTE Trial: As DOACs Face Off, Apixaban Confirmed Safer  MedscapeBlood-thinning drug Eliquis likely safer for patients with deep blood clots, study suggests  CBCVenous Thrombosis Trial Published in The New England Journal of Medicine  McGill UniversityApixaban bests rivaroxaban in new DOAC comparison  Cardiovascular BusinessEliquis proves safer than Xarelto for patients with deep blood clots  Reuters